Eicosapentaenoic Acid: Prevention of Coronary Artery Disease

Eicosapentaenoic Acid: Prevention of Coronary Artery Disease

0:00

A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among patients with established coronary artery disease. Mitsuhiro

A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among patients with established coronary artery disease.Mitsuhiro Yokoyamaof Kobe University told us more about it.

Click here for all the interviews from AHA 2005

Related Episodes

Tropical Health Research: London Scientist Honored

Tropical Health Research: London Scientist Honored

Brian Greenwood Brian Greenwood, London School of Hygiene and Tropical Medicine Brian Greenwood has won the Hideyo Noguchi Africa Prize for his numerous achievements in tropical disease research. He t

Routine Angioplasty Recommended After Thrombolysis

Routine Angioplasty Recommended After Thrombolysis

Warren Cantor Tony Gershlick REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction Warren Cantor, University of Toronto COMMENT: Tony Gershlick, Leicester

Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

Giorgio Scagliotti Robert Pirker GIORGIO SCAGLIOTTI, University of Turin ROBERT PIRKER, Medical University of Vienna A heated debate took place at the European Congress on Lung Cancer in Turin between